Keyword search (4,163 papers available)

"Montero-Odasso M" Authored Publications:

Title Authors PubMed ID
1 The effect of hearing ability on dual-task performance following multi-domain training in older adults with mild cognitive impairment: findings from the SYNERGIC trial Downey RI; Petersen BJ; Mohanathas N; Campos JL; Montero-Odasso M; Bherer L; Pichora-Fuller MK; Bray NW; Burhan AM; Camicioli R; Fraser S; Liu-Ambrose T; Lussier M; Middleton LE; Pieruccini-Faria F; Phillips NA; Li KZH; 41694460
SOH
2 Dementia Care Research and Psychosocial Factors Mancor E; Montero-Odasso M; Bherer L; Almeida QJ; Liu-Ambrose T; Middleton LE; Camicioli R; Li K; 41448628
CONCORDIA
3 Clinical Manifestations Gagnon C; Montero-Odasso M; Zou G; Speechley MR; Almeida QJ; Liu-Ambrose T; Middleton LE; Camicioli R; Bray NW; Li K; Fraser S; Pieruccini-Faria F; Burhan AM; Berryman N; Lussier M; Son S; Shoemaker JK; Bherer L; 41447475
CONCORDIA
4 Public Health Pieruccini-Faria F; Son S; Liu-Ambrose T; Burhan AM; Almeida QJ; Middleton LE; Li K; Fraser S; Bherer L; Montero-Odasso M; 41435121
CONCORDIA
5 Public Health Gurve D; Centen AP; Slack PJ; Dang-Vu TT; Belleville S; Anderson ND; Montero-Odasso M; Nygaard HB; Chertkow H; Feldman HH; Brewster PWH; Lim A; 41434309
PERFORM
6 Synergistic effects of exercise, cognitive training and vitamin D on gait performance and falls in mild cognitive impairment-secondary outcomes from the SYNERGIC trial Pieruccini-Faria F; Son S; Zou G; Almeida QJ; Middleton LE; Bray NW; Lussier M; Shoemaker JK; Speechley M; Liu-Ambrose T; Burhan AM; Camicioli R; Li KZH; Fraser S; Berryman N; Bherer L; Montero-Odasso M; 40966614
SOH
7 Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research Smith EE; Phillips NA; Feldman HH; Borrie M; Ganesh A; Henri-Bhargava A; Desmarais P; Frank A; Badhwar A; Barlow L; Bartha R; Best S; Bethell J; Bhangu J; Black SE; Bocti C; Bronskill SE; Burhan AM; Calon F; Camicioli R; Campbell B; Collins DL; Dadar M; DeMarco ML; Ducharme S; Duchesne S; Einstein G; Fisk JD; Gawryluk JR; Grossman L; Ismail Z; Itzhak I; Joshi M; Harrison A; Kroger E; Kumar S; Laforce R; Lanctot KL; Lau M; Lee L; Masellis M; Massoud F; Mitchell SB; Montero-Odasso M; Myers Barnett K; Nygaard HB; Pasternak SH; Peters J; Rajah MN; Robillard JM; Rockwood K; Rosa-Neto P; Seitz DP; Soucy JP; Trenaman SC; Wellington CL; Zadem A; Chertkow H; 39893139
CONCORDIA
8 Impact of a national dementia research consortium: The Canadian Consortium on Neurodegeneration in Aging (CCNA) Chertkow H; Phillips N; Rockwood K; Anderson N; Andrew MK; Bartha R; Beaudoin C; Bélanger N; Bellec P; Belleville S; Bergman H; Best S; Bethell J; Bherer L; Black S; Borrie M; Camicioli R; Carrier J; Cashman N; Chan S; Crowshoe L; Cuello C; Cynader M; Dang-Vu T; Das S; Dixon RA; Ducharme S; Einstein G; Evans AC; Fahnestock M; Feldman H; Ferland G; Finger E; Fisk JD; Fogarty J; Fon E; Gan-Or Z; Gauthier S; Greenwood C; Henri-Bellemare C; Herrmann N; Hogan DB; Hsiung R; Itzhak I; Jacklin K; Lanctôt K; Lim A; MacKenzie I; Masellis M; Maxwell C; McAiney C; McGilton K; McLaurin J; Mihailidis A; Mohades Z; Montero-Odasso M; Morgan D; Naglie G; Nygaard H; O' Connell M; Petersen R; Pilon R; Rajah MN; Rapoport M; Roach P; Robillard JM; Rogaeva E; Rosa-Neto P; Rylett J; Sadavoy J; St George-Hyslop P; Seitz D; Smith E; Stefanovic B; Vedel I; Walker JD; Wellington C; Whitehead V; Wittich W; 39636028
HKAP
9 Cognitive Speed in Neurodegenerative Disease: Comparing Mean Rate and Inconsistency Within and Across the Alzheimer's and Lewy Body Spectra in the COMPASS-ND Study Caballero HS; McFall GP; Gee M; MacDonald S; Phillips NA; Fogarty J; Montero-Odasso M; Camicioli R; Dixon RA; 38875040
PSYCHOLOGY
10 Effects of Exercise Alone or Combined With Cognitive Training and Vitamin D Supplementation to Improve Cognition in Adults With Mild Cognitive Impairment: A Randomized Clinical Trial Montero-Odasso M; Zou G; Speechley M; Almeida QJ; Liu-Ambrose T; Middleton LE; Camicioli R; Bray NW; Li KZH; Fraser S; Pieruccini-Faria F; Berryman N; Lussier M; Shoemaker JK; Son S; Bherer L; 37471089
PERFORM
11 Consensus Statement Regarding the Application of Biogen to Health Canada for Approval of Aducanumab Chertkow H; Rockwood K; Hogan DB; Phillips N; Montero-Odasso M; Amanullah S; Black S; Bocti C; Borrie M; Feldman H; Freedman M; Hsiung R; Kirk A; Masellis M; Nygaard H; Rajji T; Verret L; 34912492
PSYCHOLOGY
12 Comparing the effect of Cognitive vs. Exercise Training on brain MRI outcomes in healthy older adults: A systematic review Intzandt B; Vrinceanu T; Huck J; Vincent T; Montero-Odasso M; Gauthier CJ; Bherer L; 34245760
PERFORM
13 Gait variability across neurodegenerative and cognitive disorders: Results from the Canadian Consortium of Neurodegeneration in Aging (CCNA) and the Gait and Brain Study. Pieruccini-Faria F, Black SE, Masellis M, Smith EE, Almeida QJ, Li KZH, Bherer L, Camicioli R, Montero-Odasso M 33590967
PSYCHOLOGY
14 CCCDTD5 recommendations on early non cognitive markers of dementia: A Canadian consensus Montero-Odasso M; Pieruccini-Faria F; Ismail Z; Li K; Lim A; Phillips N; Kamkar N; Sarquis-Adamson Y; Speechley M; Theou O; Verghese J; Wallace L; Camicioli R; 33094146
CRDH
15 Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia. Ismail Z, Black SE, Camicioli R, Chertkow H, Herrmann N, Laforce R, Montero-Odasso M, Rockwood K, Rosa-Neto P, Seitz D, Sivananthan S, Smith EE, Soucy JP, Vedel I, Gauthier S, CCCDTD5 participants 32725777
PERFORM
16 Guidelines for Gait Assessments in the Canadian Consortium on Neurodegeneration in Aging (CCNA). Cullen S, Montero-Odasso M, Bherer L, Almeida Q, Fraser S, Muir-Hunter S, Li K, Liu-Ambrose T, McGibbon CA, McIlroy W, Middleton LE, Sarquis-Adamson Y, Beauchet O, McFadyen BJ, Morais JA, Camicioli R, Canadian Gait and Cognition Network 29977431
ENCS
17 SYNERGIC TRIAL (SYNchronizing Exercises, Remedies in Gait and Cognition) a multi-Centre randomized controlled double blind trial to improve gait and cognition in mild cognitive impairment. Montero-Odasso M, Almeida QJ, Burhan AM, Camicioli R, Doyon J, Fraser S, Li K, Liu-Ambrose T, Middleton L, Muir-Hunter S, McIlroy W, Morais JA, Pieruccini-Faria F, Shoemaker K, Speechley M, Vasudev A, Zou GY, Berryman N, Lussier M, Vanderhaeghe L, Bherer L 29661156
PERFORM
18 Consensus on Shared Measures of Mobility and Cognition: From the Canadian Consortium on Neurodegeneration in Aging (CCNA). Montero-Odasso M, Almeida QJ, Bherer L, Burhan AM, Camicioli R, Doyon J, Fraser S, Muir-Hunter S, Li KZH, Liu-Ambrose T, McIlroy W, Middleton L, Morais JA, Sakurai R, Speechley M, Vasudev A, Beauchet O, Hausdorff JM, Rosano C, Studenski S, Verghese J, Canadian Gait and Cognition Network 30101279
PERFORM

 

Title:Public Health
Authors:Gurve DCenten APSlack PJDang-Vu TTBelleville SAnderson NDMontero-Odasso MNygaard HBChertkow HFeldman HHBrewster PWHLim A
Link:https://pubmed.ncbi.nlm.nih.gov/41434309/
DOI:10.1002/alz70860_107491
Publication:Alzheimer s & dementia : the journal of the Alzheimer s Association
Keywords:
PMID:41434309 Category: Date Added:2025-12-23
Dept Affiliation: PERFORM
1 University of Toronto, Toronto, ON, Canada.
2 Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
3 University of British Columbia, Vancouver, BC, Canada.
4 Centre de recherche de l'Institut universitaire de gériatrie de Montréal, Montreal, QC, Canada.
5 PERFORM Centre, Concordia University, Montreal, QC, Canada.
6 Concordia University, Montreal, QC, Canada.
7 Research Centre, Institut universitaire de gériatrie de Montréal, Montreal, QC, Canada.
8 Department of Psychology, Université de Montréal, Montreal, QC, Canada.
9 Rotman Research Institute, Baycrest Academy for Research and Education, Toronto, ON, Canada.
10 Rotman Research Institute, Toronto, ON, Canada.
11 Ben & Hilda Katz Interprofessional Research Centre in Geriatric and Dementia Care, Toronto, ON, Canada.
12 Kimel Family Centre for Brain Health and Wellness, Toronto, ON, Canada.
13 Western Univeristy, London, ON, Canada.
14 Lawson Health Research Institute, London, ON, Canada.
15 Schulich School of Medicine & Dentistry, Division of Geriatric Medicine, Western University, London, ON, Canada.
16 UBC Hospital Clinic for Alzheimer Disease and Related Disorders, Vancouver, BC, Canada.
17 Division of Neurology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
18 Kimel Family Centre for Brain Health and Wellness and Anne & Allan Bank Centre for Clinical Research Trials, Baycrest Health Sciences, Toronto, ON, Canada.
19 Baycrest and Rotman Research Institute, Toronto, ON, Canada.
20 Baycrest Academy, Toronto, ON, Canada.
21 University of California San Diego, Department of Neurosciences, La Jolla, CA, USA.
22 Alzheimer's Disease Cooperative Study (ADCS), University of California San Diego, La Jolla, CA, USA.
23 Cognition & Technology Research Group, Institute on Aging and Lifelong Health, University of Victoria, Victoria, BC, Canada.
24 University of Victoria, Victoria, BC, Canada.

Description:

Background: Older adults experience considerable day-to-day variability in cognitive function. We aimed to test the hypothesis that this is in part related to sleep, and determine which EEG sleep features are most important in supporting day to day cognitive resilience.

Method: We analyzed data from 149 adults at high risk for dementia participating in the Brain Health Pro (BHPro) study. At BHPro baseline, participants underwent up to 3 nights of overnight ambulatory EEG using the MUSE-S (Interaxon, Toronto, Canada) as well as multi-day app-based cognitive testing (MyCogHealth, Victoria, Canada). Of 350 participants, 149 had EEG and cognitive evaluation that overlapped by at least 1 day. We performed automated sleep staging and computed frontal NREM (N2 and N3) delta power and REM theta power. We used linear mixed effect models to relate each morning's composite global cognitive test results to the previous night's sleep measures.

Result: 149 individuals had >=1 cognitive evaluation within 12 hours of an overnight EEG recording. Of these, 63 had 2 nights, and 37 had >=3 nights. Greater % REM sleep (+0.15 per 1SD greater REM sleep, SE 0.04 p = 0.0001) and relative REM theta power (+0.08 per 1SD greater relative REM theta power, SE 0.04, p = 0.02) the night before were associated with better cognitive performance the next morning, and there was a non-significant positive relationship (+0.06 per 1SD difference, SE 0.04, p = 0.11) between NREM delta power and cognitive performance the following morning. These effects were particularly strong in those with mild cognitive impairment (delta power interaction p = 0.055; theta power interaction p = 0.02) CONCLUSION: REM sleep theta power and NREM delta power may support day to day cognitive performance in older adults at high risk for dementia, particularly those with mild cognitive impairment, and may represent electrophysiologic therapeutic targets to support cognitive resilience.





BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University